Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.

CONCLUSION: Our prospective study indicates that piperacillin-induced ddab occur more frequently in patients with CF than previously suggested. The question related to the significance of piperacillin-dependent antibodies may reflect new aspects in this field. PMID: 31724753 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31724753?dopt=Abstract

Source: Transfusion - November 13, 2019 Category: Hematology Authors: Roehmel J, Specht P, Staab D, Schwarz C, Salama A, Mayer B Tags: Transfusion Source Type: research

More News: Anemia | Antibiotic Therapy | Cystic Fibrosis | Hematology | Study